RDN (NYSE: RDN) Form 144 shows $613,384.91 value and 18,202 vested shares

Rhea-AI Filing Summary

RDN filed a Form 144 reporting proposed transactions in its common stock. The filing lists $613,384.91 alongside an identifier 136272409 and shows brokerage listed as Fidelity Brokerage Services LLC with an exchange tag NYSE.

The filing itemizes two restricted stock vesting events tied to compensation: 17,532 shares vesting 03/06/2025 and 670 shares vesting 05/15/2025. The form lists a date of 02/20/2026.

Insights

Equity Compensation Analyst

Form 144 shows planned sales tied to recent restricted stock vesting.

The excerpt lists two compensation-related restricted stock vesting events: 17,532 shares (vesting 03/06/2025) and 670 shares (vesting 05/15/2025). The filing pairs these items with an aggregate value of $613,384.91, which appears in the form.

Timing and final sale mechanics are not detailed in the excerpt; subsequent filings or broker reports would clarify execution and whether proceeds go to the issuer or selling holder.

Securities Counsel

The form names Fidelity Brokerage Services LLC and includes an NYSE designation.

The filing identifies Fidelity Brokerage Services LLC at 900 Salem Street Smithfield RI 02917 and an exchange label NYSE. It also shows numeric identifiers including 18202 and 136272409.

Legal and procedural details such as registration status, selling‑holder identity, and exact distribution methods are not present in the excerpt; any regulatory qualifiers or limitations are therefore not shown here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	18202	613384.91	136272409	02/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/06/2025	Restricted Stock Vesting	Issuer			17532	03/06/2025	Compensation
Common	05/15/2025	Restricted Stock Vesting	Issuer			670	05/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the RDN Form 144 disclose about planned share sales?

It reports proposed transactions in common stock, listing $613,384.91 and identifiers 18202 and 136272409. The form names Fidelity Brokerage Services LLC and an NYSE designation.

How many shares from restricted stock vesting are listed on the RDN excerpt?

The excerpt lists two vesting events totaling 18,202 shares: 17,532 vesting on 03/06/2025 and 670 vesting on 05/15/2025. These are described as compensation-related vesting.

Does the Form 144 excerpt state who will receive proceeds from any sales?

The excerpt does not specify proceeds recipients. It lists brokerage and numeric amounts such as $613,384.91, but cash‑flow treatment is not detailed in the provided text.

What broker and address are named in the RDN filing excerpt?

The filing names Fidelity Brokerage Services LLC with address 900 Salem Street Smithfield RI 02917. The broker is identified in the securities section of the excerpt.

What effective or filing date appears on the RDN excerpt?

The excerpt shows a date of 02/20/2026 near the securities header. Vesting dates listed are 03/06/2025 and 05/15/2025 for the two restricted stock events.